In every issue, you’ll find the hottest topics of interest to our readers along with cutting-edge health information.
Thirty years after people first started dying from a then-unknown virus, we face a thrilling tipping point in AIDS history.
The end of AIDS. Doesn’t that have a wonderful ring to it?
I was so thrilled to see my friend Dottie Rains on the cover of POZ. I have known her for many years—what a wonderful person and role model.
Kevin Fenton explains a new approach to prevent HIV in the communities most at risk.
Two changes to health care (one actual and one proposed) could make it easier for Americans to access lifesaving tools when they’re needed.
Earlier this year, Gilead Sciences became the first manufacturer of HIV meds to join the Medicines Patent Pool Foundation.
HIV-positive individuals are often presumed guilty and must prove themselves otherwise when it comes to laws that criminalize HIV, but that ma...
The law has finally started to catch up with the science—in Canada, at least.
Officials in the Philippines are fighting a growing trend of using geckos (small lizards) to treat AIDS.
Pre-exposure prophylaxis, or PrEP, is the practice of people at risk for HIV taking daily doses of antiretroviral medication (ARVs) to...
Treatment options and help are available for people with HIV—and without immigration papers.
A new entry inhibitor (EI) is in the works.
Researchers with the University of North Carolina at Chapel Hill have found that just being in an HIV clinical trial can enhance your health.&...
To work most effectively, protease inhibitors (PIs) have long relied on a boost from Norvir (ritonavir).
Recent advances in AIDS research have increased the hope of finding a functional, or therapeutic, cure for HIV.
Hearing loss in people with HIV results from age, race and other risk factors, not the virus.
At a U.N. summit this past June, the Elizabeth Glaser Pediatric AIDS Foundation announced its "Global Plan Towards the Elimination of New HIV...
A study by the Department of Veterans Affairs (VA) found that, while some HIV meds can play a role in the disproportionately high incidence of...
Every day, all day, in and out. It’s so natural, you do it in your sleep.
Orbit Clanton, co-founder of Perceptions for People with Disabilities, was diagnosed with GRID in 1982. (Watch video.)